Emvision Medical Devices
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 27 July 2026
- Reported shorts
- 18
- Shares on issue
- 92.956M
Emvision Medical Devices (EMV) Short Interest
Emvision Medical Devices (ASX:EMV) had 0.00% of shares reported as short positions as of 27 July 2026, representing 18 shares. Emvision Medical Devices operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Emvision Medical Devices
Emvision Medical Devices is focused on the development and commercialization of its portable brain scanner technology. Their device aims to provide rapid, cost-effective brain imaging at the point of care, potentially transforming stroke diagnosis and management. The company is positioned to address a significant unmet need in emergency medical settings.
Company profile →Emvision Medical Devices (ASX:EMV) has 0.00% of its shares on issue reported as short positions as of 27 July 2026, or about 18 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.31% in April 2025. EMV is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads EMV today
- Zanger BreakoutWatchScore 34rank 378 of 1893
- CAN SLIMWatchScore 9rank 1245 of 1549
- Minervini Trend TemplateWatchScore 10rank 1281 of 1684
- Crowded-Short BreakoutNot a candidate
- Quality compoundersWatchScore 25rank 533 of 1660
Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
EMV fundamentals
In the year to 30 Jun 2026, Emvision Medical Devices (ASX:EMV) recorded revenue of A$8.8M and a net loss after tax of A$8.3M. A year earlier it recorded revenue of A$5.6M and a net loss after tax of A$9.8M. Year-on-year growth: revenue +57.2% (FY). Net margin −94.0%, return on equity −66.4% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest EMV news
All news- Date of AGM & Closing Date of Director Nominations
asx · 28 Sept 2026
- $4.3m Non-Dilutive R&D Tax Rebate Received
asx · 27 Sept 2026
- EMVision completes first road test of portable stroke scanner
stockhead · 16 Sept 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss EMV
Start a research thread or post the first pulse update